These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32060221)

  • 21. Multicenter Study on Incubation Conditions for Environmental Monitoring and Aseptic Process Simulation.
    Guinet R; Berthoumieu N; Dutot P; Triquet J; Ratajczak M; Thibaudon M; Bechaud P; Arliaud C; Miclet E; Giordano F; Larcon M; Arthaud C
    PDA J Pharm Sci Technol; 2017 1/2; 71(1):43-49. PubMed ID: 27593691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Media-fill simulation tests in manual and robotic aseptic preparation of injection solutions in syringes.
    Krämer I; Federici M; Kaiser V; Thiesen J
    J Oncol Pharm Pract; 2016 Apr; 22(2):195-204. PubMed ID: 25549919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the BioVigilant IMD-A, a novel optical spectroscopy technology for the continuous and real-time environmental monitoring of viable and nonviable particles. Part II. Case studies in environmental monitoring during aseptic filling, intervention assessments, and glove integrity testing in manufacturing isolators.
    Miller MJ; Walsh MR; Shrake JL; Dukes RE; Hill DB
    PDA J Pharm Sci Technol; 2009; 63(3):259-83. PubMed ID: 20069799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dry-heat Depyrogenation Ovens for Pharmaceutical Compounding Facilities.
    Weller T; Kragseth R; Dullinger R; Illum H; Perry A
    Int J Pharm Compd; 2015; 19(3):182-92. PubMed ID: 26714359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality Control Testing for Tracking Endotoxin-Producing Gram-Negative Bacteria during the Preparation of Polyvalent Snake Antivenom Immunoglobulin.
    Sheraba NS; Diab MR; Yassin AS; Amin MA; Zedan HH
    PDA J Pharm Sci Technol; 2015; 69(4):499-510. PubMed ID: 26242786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of rapid microbiological methods for the risk assessment of controlled biopharmaceutical environments.
    Sandle T; Leavy C; Jindal H; Rhodes R
    J Appl Microbiol; 2014 Jun; 116(6):1495-505. PubMed ID: 24575809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some observations on airborne particles in the critical areas of a blow-fill-seal machine.
    Sundström S; Ljungqvist B; Reinmüller B
    PDA J Pharm Sci Technol; 2009; 63(1):71-80. PubMed ID: 19455943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Panel discussion: environmental sampling in an aseptic environment. I. Microbiological environmental monitoring.
    Raiman HL
    Bull Parenter Drug Assoc; 1974; 28(6):253-60. PubMed ID: 4616742
    [No Abstract]   [Full Text] [Related]  

  • 29. Preventing Cross-Contamination during Lyophilization: GMP and Occupational Cleaning Requirements for Nonproduct and Indirect Product-Contact Parts.
    Denk R; Flückiger A; Kisaka H; Krause S; Maeck R; Restetzki L; Schreiner A; Schulze R
    PDA J Pharm Sci Technol; 2019; 73(5):487-495. PubMed ID: 31420508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between air movements and the dispersion of contaminants: clean zones with unidirectional air flow.
    Ljungqvist B; Reinmüller B
    J Parenter Sci Technol; 1993; 47(2):60-9. PubMed ID: 8515346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative Microbial Risk Assessment of Pharmaceutical Products.
    Eissa ME
    PDA J Pharm Sci Technol; 2017; 71(3):245-251. PubMed ID: 27974628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, development and qualification of a microbiological challenge facility to assess the effectiveness of BFS aseptic processing.
    Leo F; Poisson P; Sinclair CS; Tallentire A
    PDA J Pharm Sci Technol; 2005; 59(1):33-48. PubMed ID: 15796134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. July-August 2020 Issue.
    Levy R
    PDA J Pharm Sci Technol; 2020; 74(4):367. PubMed ID: 32737241
    [No Abstract]   [Full Text] [Related]  

  • 34. Contamination Control.
    Akers MJ
    Int J Pharm Compd; 2015; 19(3):232-8. PubMed ID: 26714364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment of critical contamination risk locations ("hot spots") in environmental monitoring by means of three-dimensional airflow analysis and particulate evaluation.
    Katayama H; Higo T; Tokunaga Y; Hiyama Y; Morikawa K
    PDA J Pharm Sci Technol; 2005; 59(1):49-63. PubMed ID: 15796135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Some aspects on the use of the Biotest RCS Air Sampler in unidirectional air flow testing.
    Ljungqvist B; Reinmüller B
    J Parenter Sci Technol; 1991; 45(4):177-80. PubMed ID: 1770410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of portable devices for medicine quality screening: Lessons learnt, recommendations for implementation, and future priorities.
    Caillet C; Vickers S; Vidhamaly V; Boutsamay K; Boupha P; Zambrzycki S; Luangasanatip N; Lubell Y; Fernández FM; Newton PN
    PLoS Med; 2021 Sep; 18(9):e1003747. PubMed ID: 34591861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality control analytical methods: strategies to ensure a robust quality-control microbiology program.
    Griffiths T; Connors A
    Int J Pharm Compd; 2013; 17(2):130-4. PubMed ID: 23696174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aseptic work under various hygienic conditions.
    Aslund B; Olson OT; Sandell E
    Acta Pharm Suec; 1977; 14(5-6):517-24. PubMed ID: 596167
    [No Abstract]   [Full Text] [Related]  

  • 40. Microbial diversity in pharmaceutical product recalls and environments.
    Jimenez L
    PDA J Pharm Sci Technol; 2007; 61(5):383-99. PubMed ID: 18047177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.